| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3296463 | Gastroenterology | 2011 | 15 Pages |
Abstract
EFD BCG controls severe colitis in mice by expanding T regulatory cell populations and PPAR-γ and might be developed to treat patients with inflammatory bowel disease.
Keywords
NF-κBRXRTregRetinoid X receptorTGFIL-10EFDMLNPPARBCGDSSBacillus Calmette–GuérinMPOinterferonIFNinterleukintransforming growth factorT regulatory celldextran sodium sulfatenuclear factor κBImmune regulationmyeloperoxidaseTherapeutic vaccinemesenteric lymph nodeperoxisome proliferator-activated receptor
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Micheline Lagranderie, Christoph Kluge, Helene Kiefer-Biasizzo, Mohammad Abolhassani, Marie-Anne Nahori, Catherine Fitting, Michel Huerre, Antonio Bandeira, Herve Bercovier, Gilles Marchal,